FDA issued a Warning Letter to Baxter Healthcare Corp. on 1/17/2014 for a previous inspection.
483 Baxalta US Jul 2017

483 Baxalta US Jul 2017

Jacqueline Diaz Albert FDA$119.00 - Available Now

FDA investigators audited the Baxalta US - Round Lake, IL, United States facility and issued inspectional observations (via FDA 483) on 14 Jul 2017.

Product details

  • Category: Biologics
  • Inspection end: 14 Jul 2017
  • Location: Round Lake, United States
  • FEI: 1416980
Add To Cart